Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This artificial peptide duplicates the actions of naturally produced GLP-1, a https://socialeweb.com/story6277261/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes